Further mechanistic insights of the IL-22 signaling were given in a recent studies, where indoleamine 2,3-dioxygenase 1 (IDO), an enzyme that is present in many immune cells and activated during inflammation, was linked to the gut microbiota and obesity (247). This evidence concerns the gene IDO1 and obesity disorder.